Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nanoparticles
100%
Weight Loss
100%
Receptor-binding Domain
100%
Bioengineering
100%
Mortality Loss
100%
Pseudovirus
100%
SARS-CoV-2 Receptor Binding Domain
100%
COVID-19
36%
COVID-19 Vaccine
36%
Protective Efficacy
18%
Vaccine Candidate
18%
Highly Effective
9%
Receptor Binding
9%
Binding Function
9%
IgG Antibody
9%
Manufacturing Cost
9%
N-terminal Domain
9%
Neutralizing Antibodies
9%
Eukaryotic Expression System
9%
Multiple Surfaces
9%
Particle-based
9%
High Titer
9%
Flexible Platform
9%
Manufacturing Time
9%
Immunogenic
9%
Particle-bound
9%
COVID-19 Pandemic
9%
Prokaryotic System
9%
Non-replicating
9%
Icosahedral Symmetry
9%
Nanoparticle Vaccine
9%
K18-hACE2 Mice
9%
Medicine and Dentistry
Receptor Binding
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Nanoparticle
100%
COVID-19 Vaccine
30%
Health Care Cost
7%
Amino Terminal Sequence
7%
Neutralizing Antibody
7%
K 18
7%
COVID-19
7%
Biochemistry, Genetics and Molecular Biology
Binding Domain
100%
SARS Coronavirus
100%
Receptor Binding
100%
Spike
15%
Conformation
7%
N-Terminus
7%
Neutralizing Antibody
7%
Titer
7%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Nanoparticle
100%
SARS Coronavirus
100%
COVID-19 Vaccine
30%
Neutralizing Antibody
7%
K 18
7%
Immunology and Microbiology
Receptor Binding
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
38%
Spike
15%
Amino Terminal Sequence
7%
Conformation
7%
Titer
7%
Neutralizing Antibody
7%